510 related articles for article (PubMed ID: 8840361)
1. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
4. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
5. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Graybill JR
Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302
[No Abstract] [Full Text] [Related]
6. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
7. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
Pintado García V; Martín Dávila P; Muñoz Labián V; Quereda Rodríguez-Navarro C
Rev Clin Esp; 1999 Jul; 199(7):480. PubMed ID: 10481571
[No Abstract] [Full Text] [Related]
9. Treatment of cryptococcal meningitis.
Larsen RA
N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380127
[No Abstract] [Full Text] [Related]
10. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
11. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
Riantawan P; Ponglertnapakorn P
J Med Assoc Thai; 1996 Jul; 79(7):429-33. PubMed ID: 8855621
[TBL] [Abstract][Full Text] [Related]
13. Treating cryptococcal meningitis in people with HIV.
BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
[No Abstract] [Full Text] [Related]
14. Recent advances in the management of cryptococcal meningitis in patients with AIDS.
Powderly WG
Clin Infect Dis; 1996 May; 22 Suppl 2():S119-23. PubMed ID: 8722838
[TBL] [Abstract][Full Text] [Related]
15. Free fluconazole for cryptococcal meningitis: too little of a good thing?
Hamill RJ
Clin Infect Dis; 2006 Oct; 43(8):1074-6. PubMed ID: 16983623
[No Abstract] [Full Text] [Related]
16. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
Schaars CF; Meintjes GA; Morroni C; Post FA; Maartens G
BMC Infect Dis; 2006 Jul; 6():118. PubMed ID: 16846523
[TBL] [Abstract][Full Text] [Related]
17. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
[No Abstract] [Full Text] [Related]
18. [Therapy of candidiasis and cryptococcosis in AIDS].
Just-Nübling G
Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
[TBL] [Abstract][Full Text] [Related]
19. [Focusing on therapy of systemic mycoses].
Internist (Berl); 1995 Dec; 36(12 Suppl):1-12. PubMed ID: 9022383
[No Abstract] [Full Text] [Related]
20. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
